Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127395171 | 12739517 | 1 | I | 20160829 | 20160913 | 20160913 | EXP | CN-JNJFOC-20160826677 | JANSSEN | FENG L, HONGZHONG J, ZHIXIN H, HONGCHUN L, JU Q, FEI S. MODERATE TO SEVERE PSORIASIS TREATED WITH INFLIXIMAB IN 17 CASES. CHIN J DERMATOL JUN-2016;49/6:437 - 438. | 0.00 | A | Y | 0.00000 | 20160913 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127395171 | 12739517 | 1 | PS | INFLIXIMAB | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | WEEK 0, 2, 6, 14, ONCE FOR EACH WEEK, 4 TIMES IN TOTAL | Y | U | 103772 | 5 | MG/KG | LYOPHILIZED POWDER |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127395171 | 12739517 | 1 | Psoriasis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127395171 | 12739517 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127395171 | 12739517 | Abdominal pain | |
| 127395171 | 12739517 | Antinuclear antibody positive | |
| 127395171 | 12739517 | Asphyxia | |
| 127395171 | 12739517 | Chest X-ray abnormal | |
| 127395171 | 12739517 | Eczema | |
| 127395171 | 12739517 | Haematology test abnormal | |
| 127395171 | 12739517 | Infusion related reaction | |
| 127395171 | 12739517 | Joint swelling | |
| 127395171 | 12739517 | Lupus-like syndrome | |
| 127395171 | 12739517 | Neoplasm malignant | |
| 127395171 | 12739517 | Off label use | |
| 127395171 | 12739517 | Palpitations | |
| 127395171 | 12739517 | Platelet count decreased | |
| 127395171 | 12739517 | Product use issue | |
| 127395171 | 12739517 | Skin lesion | |
| 127395171 | 12739517 | Tonsillitis | |
| 127395171 | 12739517 | Upper respiratory tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |